Systemic Retinoid Therapy: A Status Report on Optimal Use and Safety of Long-Term Therapy - 09/08/11
Doi : 10.1016/j.det.2007.02.002
Alpesh Desai, DO a, b, ⁎ 
, Francisca Kartono, BS b, James Q. Del Rosso, DO, FAOCD c
, Francisca Kartono, BS b, James Q. Del Rosso, DO, FAOCD c a Heights Dermatology and Aesthetic Center, 2120 Ashland Street, Houston, TX 77008, USA
b Western University of Health Sciences, 309 E. Second Street, Pomona, CA 91766, USA
c Valley Hospital Medical Center, 620 Shadow Lane, Las Vegas, NY 89106, USA
Corresponding author. Heights Dermatology and Aesthetic Center, 2120 Ashland Street, Houston, TX 77008.Abstract |
Systemic retinoids are an important component of the dermatology treatment armamentarium offering unique therapeutic properties, and are widely used to treat a large spectrum of skin disorders. Rational selection of candidates for treatment, knowledge regarding appropriate and optimal use, awareness of common and uncommon potential adverse reactions, and proper use of clinical and laboratory monitoring can result in effective and safe treatment of several severe skin disorders that impact poorly on the overall health and quality of life of affected patients.
Le texte complet de cet article est disponible en PDF.Plan
© 2007
Elsevier Inc. Tous droits réservés.
Vol 25 - N° 2
P. 185-193 - avril 2007 Retour au numéro
Article précédent
- Advances in Topical and Systemic Antifungals
- Alexandra Y. Zhang, William L. Camp, Boni E. Elewski
- Suggested Guidelines for Patient Monitoring: Hepatic and Hematologic Toxicity Attributable to Systemic Dermatologic Drugs
- Stephen E. Wolverton, Kathleen Remlinger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?